Despite the advances in the field of stem cell transplantation, relapse remains a major source of mortality. CIBMTR data identify relapse as the cause of death in 78% of autologous transplant patients, 34% of related allogeneic transplant patients, and 23% of unrelated transplant patients. With the advent of reduced intensity transplants allowing more patients to proceed with transplant, there have been reports of higher than anticipated relapses. Management of relapse post-transplant requires assessment of multiple host/recipient factors and often is limited by the compromised status of the recipient.
|Original language||English (US)|
|Title of host publication||Blood and Marrow Transplant Handbook|
|Subtitle of host publication||Comprehensive Guide for Patient Care|
|Publisher||Springer New York|
|Number of pages||6|
|State||Published - Dec 1 2011|
ASJC Scopus subject areas